Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Strategic Asset Allocation Index
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Strategic Asset Allocation Index of 51.4% as of June 2023. Strategic assets (PP&E of CN¥1.42 Billion plus long-term investments of CN¥-) total CN¥1.42 Billion, measured against net assets of CN¥2.77 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Wanbangde Pharmaceutical Holding Group Co Ltd Strategic Asset Allocation Index (2003–2021)
This chart shows how Wanbangde Pharmaceutical Holding Group Co Ltd's Strategic Asset Allocation Index has evolved across 19 annual periods from 2003 to 2021. As of June 2023, the index stands at 51.4%, representing strategic assets of CN¥1.42 Billion against net assets of CN¥2.77 Billion CNY. Explore 002082 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2021, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002082 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 42.8% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥- | CN¥2.74 Billion | ▼ -18.0 pp |
| 2020 | 60.8% | CN¥1.74 Billion | CN¥1.74 Billion | CN¥- | CN¥2.86 Billion | ▼ -3.7 pp |
| 2019 | 64.5% | CN¥1.23 Billion | CN¥1.23 Billion | CN¥- | CN¥1.91 Billion | ▲ +48.4 pp |
| 2018 | 16.2% | CN¥278.60 Million | CN¥278.60 Million | CN¥- | CN¥1.72 Billion | ▼ -15.6 pp |
| 2017 | 31.8% | CN¥509.95 Million | CN¥509.95 Million | CN¥- | CN¥1.60 Billion | ▲ +2.9 pp |
| 2016 | 28.9% | CN¥403.55 Million | CN¥403.55 Million | CN¥- | CN¥1.40 Billion | ▼ -4.6 pp |
| 2015 | 33.5% | CN¥451.11 Million | CN¥451.11 Million | CN¥- | CN¥1.35 Billion | ▼ -2.2 pp |
| 2014 | 35.7% | CN¥462.27 Million | CN¥462.27 Million | CN¥- | CN¥1.30 Billion | ▼ -9.3 pp |
| 2013 | 45.0% | CN¥534.18 Million | CN¥534.18 Million | CN¥- | CN¥1.19 Billion | ▼ -10.0 pp |
| 2012 | 55.0% | CN¥603.37 Million | CN¥603.37 Million | CN¥- | CN¥1.10 Billion | ▼ -3.7 pp |
| 2011 | 58.7% | CN¥618.82 Million | CN¥618.82 Million | CN¥- | CN¥1.05 Billion | ▼ -0.6 pp |
| 2010 | 59.3% | CN¥555.12 Million | CN¥555.12 Million | CN¥- | CN¥936.13 Million | ▼ -13.2 pp |
| 2009 | 72.5% | CN¥588.26 Million | CN¥588.26 Million | CN¥- | CN¥811.59 Million | ▼ -6.7 pp |
| 2008 | 79.2% | CN¥563.86 Million | CN¥563.86 Million | CN¥- | CN¥712.31 Million | ▼ -28.9 pp |
| 2007 | 108.1% | CN¥448.58 Million | CN¥448.58 Million | CN¥- | CN¥415.12 Million | ▲ +9.8 pp |
| 2006 | 98.3% | CN¥351.63 Million | CN¥351.63 Million | CN¥- | CN¥357.72 Million | ▼ -103.2 pp |
| 2005 | 201.5% | CN¥308.10 Million | CN¥308.10 Million | CN¥- | CN¥152.88 Million | ▲ +33.5 pp |
| 2004 | 168.0% | CN¥228.80 Million | CN¥228.80 Million | CN¥- | CN¥136.17 Million | ▲ +29.2 pp |
| 2003 | 138.8% | CN¥136.77 Million | CN¥136.77 Million | CN¥- | CN¥98.53 Million | — |